Table 1 Characteristics of the tested subjects.
From: Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Parameter | Infected subjects until January 2021 (%) | Non-infected subjects until January 2021 (%) | Infected subjects during January–October 2021 (%) |
|---|---|---|---|
Subjects (n) | |||
Female (90) | 23 | 77 | 0 |
Male (13) | 29 | 71 | 0 |
Average age of total (years) | 37.81 | 41.00 | 40.26 |
Average age of women (years) | 39.14 | 41.48 | 40.95 |
Average age of men (years) | 28.50 | 36.40 | 34.14 |
Major comorbidities (%) | Overweight (BMI ≤ 25) | 23 | |
Non-obesity overweight (BMI = 26–30) | 13 | ||
Obesity (BMI > 30) | 10 | ||
Cardiovascular disease | 9 | ||
Arterial hypertension | 6 | ||
Diabetes | 4 | ||
Non-immune thyroidian disease | 4 | ||
Hypothyroidism | 4 | ||
Autoimmune thyroiditis | 4 | ||
Allergies | 3 | ||
Chronic venous insufficiency | 3 | ||
Various other comorbidities | Under 2% | ||
